- Home
- ZVRA vs BALY Comparison
ZVRA vs BALY Comparison
Compare ZVRA & BALY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZVRA | BALY |
|---|---|---|
| Founded | 2006 | 2004 |
| Country | United States | United States |
| Employees | N/A | 11700 |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 741.9M | 731.8M |
| IPO Year | 2015 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ZVRA | BALY |
|---|---|---|
| Price | $12.97 | $14.76 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 5 |
| Target Price | ★ $23.00 | $12.40 |
| AVG Volume (30 Days) | ★ 2.1M | 40.6K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 159.21 | 8.37 |
| EPS | ★ 0.60 | N/A |
| Revenue | $106,470,000.00 | ★ $2,436,189,000.00 |
| Revenue This Year | $37.27 | $21.50 |
| Revenue Next Year | $53.42 | $5.45 |
| P/E Ratio | $21.08 | ★ N/A |
| Revenue Growth | ★ 350.91 | N/A |
| 52 Week Low | $7.16 | $8.79 |
| 52 Week High | $14.27 | $20.74 |
Technical Indicators
Market Signals| Indicator | ZVRA | BALY |
|---|---|---|
| Relative Strength Index (RSI) | 60.90 | 57.75 |
| Support Level | $8.26 | $12.34 |
| Resistance Level | $14.27 | $15.64 |
| Average True Range (ATR) | 0.75 | 1.03 |
| MACD | 0.02 | -0.05 |
| Stochastic Oscillator | 65.13 | 68.71 |
Price Performance
Historical ComparisonAbout ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.
About BALY Bally's Corporation
Ballys Corp is a gaming, hospitality, entertainment, and technology company operating across casino, interactive, and lottery markets. It provides physical and interactive gaming experiences, including casino gaming, iGaming, sportsbook, online bingo, free-to-play games, and technology-driven lottery solutions. The company's segments include Casinos & Resorts, which generates maximum revenue and operates casino and resort properties, a horse racetrack, and a golf course; Bally's Intralot B2B, which provides lottery and technology services; Bally's Intralot B2C, which includes interactive gaming and lottery operations, including a UK casino; and North America Interactive, which includes sports betting and iGaming operations in the United States and Canada.